Transcatheter Embolization and Occlusion Devices Market (By Type: Coil [Pushable Coils, Detachable Coils], Non Coil [Flow Diverting Devices, Embolization Particles, Liquid Embolics, Others; By Application: Peripheral Vascular Disease [Arterial Blockage, Venous Blood clot, Others], Oncology [Liver Cancer, Pancreatic Cancer, Breast Cancer, Kidney Cancer, Others], Neurology [Brain Aneurysm, Cerebral Arteriovenous Malformations, Others], Urology [Benign Prostatic Hyperplasia/Urinary Retention, Others (Varicocele), Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction

Transcatheter embolism and occlusion devices refer to the passage or insertion into the blood vessel of a synthetic embolus by a fine catheter to block blood flow in a specific area of the body. Embolization of transcatheter is a minimally invasive procedure performed in interventional radiology to reduce tumor blood circulation. In some cases, embolic synthetic materials are covered with chemotherapeutic products which have a two-fold effect on the blockage of blood supply and inducing cytotoxicity in a number of ways to tumor attacks. In addition, aneurysms which refer to bulge or sack formation in a faint artery wall can also be controlled or prevented, abnormative connections between arteries and veins eliminated or aneurysms treated. Embolizing transcatheters is a less invasive and highly effective means of controlling bleeding in comparison to open invasive procedures. The first line of treatment in gastrointestinal bleeding is considered to be catheter embolization. This can be done alone or in combination with other therapies like surgery or radiation. The procedure is started by means of radiography to visualize the blood vessel, which is then inserted into the desired vessel and advanced by an interventional radiologist to the treatment site by a cutaneous catheter. Among females, this method offers an excellent way of shrinking and controlling heavy menstrual blood supply caused by uterine fibroid tumors.

In the past decade, the market has experienced tremendous growth. Paradigm shifts from clipping to bending have stimulated demand for embolization devices for transcatheters. On the other hand, expensive products, strict regulatory approval procedures and the requirement of experts to carry out the procedures can prevent global growth. This technique is also increasingly adopted with the use of TEO devices. The minimally invasive surgery supports non-coil products, such as embolization particles or liquid ambolics. Use of this instrument therefore helps to prevent complications such as inaccurate deployment, catheter plots and coiling-related bell deflation. Therefore, surgeons are increasingly moving to non-spinal devices, which are expected to drive the demand for TEO devices in turn. In the forecast years, Asia Pacific is anticipated to see the highest growth rate.

The report provides analysis of global Transcatheter Embolization & Occlusion Devices market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year. According to Acumen Research and Consulting, the global Transcatheter Embolization & Occlusion Devices market is expected to grow at noteworthy CAGR around 8.8 % throughout the forecast period and reach around US$ 6.1 billion by 2026.

Market Dynamics

Increasing demand is expected to promote the growth of transcatheter embolization and occlusion device market for minimally invasive surgical procedures over standard, open surgeries. This transition is the result of the advantages of minimally invasive procedures compared to open operations that include significantly low blood loss, low recovery time, low chirurgical time, reduced chance of mistakes, etc. According in 2014, for example, to a retrospective survey published by John Hopkin's Department of Surgery, hysterectomy complication and error rates in catheter embolism and open surgical procedures were 4.69 and 6.64 percent. Moreover, a significant factor contributing to market growth also lies in the increasing incidence of venous malformations leading to vascular malformations. In 2017, for example, the International Society for Auricular Reconstruction reported that 1-4 percent of the global population had incidences of vein malformations with no sexual predilection. However, the practice of transcatheter embolization without FDA guidelines leading to increased hospital read missions and expertise is expected to hinder market growth. In 2015, for example, a survey by the University of Michigan's health system reported a 27% increase in the number of major post-operative complications among patients who took catheter embolization to treat fibroid tumours.

Type Outlook

The segment Non-spinning devices includes bending aids, flow diversion devices, embolizing particles, liquid embolics, other embolization and occlusion devices, and supplies. Due to increased demand for minimally invasive surgeries, which increases demand for such devils, the non-spiral devices segment is expected to expand at the fastest growth rates during the prediction period.

The segment of accessories represented the biggest share of revenue in the past. Including various accessories and a wide range of commercially available embolization products, it became the largest segment that generates revenue in 2018. Demand for embolization particles is nevertheless expected to rise quickly as minimally invasive operations are supported. Thus, the most rapid growth rate in the future is estimated on the embolization particulates market.

Application Stance

The market is divided into peripheral vascular diseases, oncology, neurology and others on the basis of application. The segment growth is expected to be stimulated worldwide by increasing cases of fatal neurologic diseases, such as brain aneurysm and brain arteriovenous malformations. More than 140 detachable Guglielmis are currently available in different sizes, which have been used to treat over 125,000 patients throughout the world, according to the Society of Neurointerventional Surgery. Therefore during the forecast period, the market for brain aneurysm is expected to increase significantly.

Due to an embolization technique, the most efficient treatment of liver and kidney cancer is expected for the oncology segment. The techniques of embolization have become one of the most common treatment methods for various cancers, such as liver, kidney, breast, pancreas, etc. Among these are the most common type of hepatic or hepatocellular carcinoma treated through embolism. Hepatocellular carcinoma is the third largest cause of cancer deaths around the world, according to the National Center for Biotechnology Information.

Regional Stance

The majority of revenues in 2018 were represented jointly by North America and Europe. Some of the factors contributing to demand for TEO devices in these regions are the presence of advanced healthcare infrastructure, a well-defined regulatory framework and experienced health professionals to carry out procedures. During the forecast period, both regions are expected to maintain their dominance.

This growth has to do with a large population base, increased capacity for expenditure and the widespread use of state-of - the-art healthcare. In the forecast period, Asia Pacific will be registering the quickest CAGR of 12.0 %. In emerging economies, such as India, China and Malaysia, the rapidly growing medical tourism industry attracts cancer patients around the world. This is expected to rapidly increase the demand for TEO treatments in these countries and drive the regional market.

Market Segmentation

Global Transcatheter Embolization & Occlusion Devices Market, By Type

• Coil
  
  • Pushable Coils
  • Detachable Coils
• Non Coil
  
  • Flow Diverting Devices
  • Embolization Particles
  • Liquid Embolics
  • Others

Global Transcatheter Embolization & Occlusion Devices Market, By Application

• Peripheral Vascular Disease
  
  • Arterial Blockage
  • Venous Blood clot
  • Others
• Oncology
  
  • Liver Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Kidney Cancer
  • Others
• Neurology
  
  • Brain Aneurysm
  • Cerebral Arteriovenous Malformations
  • Others
• Urology
  
  • Benign Prostatic Hyperplasia/Urinary Retention
  • Others (Varicocele)
  • Others

Global Transcatheter Embolization & Occlusion Devices Market, By Geography

• North America
• U.S.
• Canada
• Mexico

• Europe
• UK
• Germany
• France
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Brazil
• Chile
• Rest of Latin America

• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• Rest of MEA

The market research study on “Transcatheter Embolization and Occlusion Devices Market (By Type: Coil [Pushable Coils, Detachable Coils], Non Coil [Flow Diverting Devices, Embolization Particles, Liquid Embolics, Others; By Application: Peripheral Vascular Disease [Arterial Blockage, Venous Blood clot, Others], Oncology [Liver Cancer, Pancreatic Cancer, Breast Cancer, Kidney Cancer, Others], Neurology [Brain Aneurysm, Cerebral Arteriovenous Malformations, Others], Urology [Benign Prostatic Hyperplasia/Urinary Retention, Others (Varicocele), Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026” offers detailed insights on global Transcatheter Embolization & Occlusion Devices market segments with market dynamics and their impact. The report provides insights on global Transcatheter Embolization & Occlusion Devices market by type, application, and major geographic regions. The report also covers basic technology development policies.

Key Players & Strategies

The Transcatheter Embolization & Occlusion Devices market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players are Boston Scientific Corporation, St. Jude Medical, Stryker Corporation, Cordis Corporation, Cook Medical, DePuy Synthes, Sirtex Medical and Nordian.

Market participants focus on expanding their business and geographical reach by means of various strategy, such as small-scale business acquisition. A further strategic approach adopted by the major companies is to maximize their profit margins by long-term contracts with hospitals and surgeons to ensure sales.